Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors
| Autor: | Zhaoxia Dai, Dan Li, Xue Wu, Qiuxiang Ou, Saiqiong Cui, Yutong Ma, Dafu Yang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Cancer Research
Lung Lung Neoplasms business.industry Receptor Protein-Tyrosine Kinases Adenocarcinoma of Lung lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease lcsh:RC254-282 medicine.anatomical_structure Text mining Oncology medicine Cancer research Adenocarcinoma Humans business Letters to the Editor Letter to the Editor Protein Kinase Inhibitors |
| Zdroj: | Cancer Communications Cancer Communications, Vol 41, Iss 2, Pp 183-186 (2021) |
| ISSN: | 2523-3548 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text